Eintrag weiter verarbeiten
PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells.
Gespeichert in:
| Zeitschriftentitel: | Blood |
|---|---|
| Personen und Körperschaften: | , , , , , |
| In: | Blood, 108, 2006, 11, S. 1416-1416 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society of Hematology
|
| Schlagwörter: |
| author_facet |
Fazio, Grazia Palmi, Chiara Attianese, Greta Giordano Biondi, Andrea Rolink, Antonius Cazzaniga, Giovanni Fazio, Grazia Palmi, Chiara Attianese, Greta Giordano Biondi, Andrea Rolink, Antonius Cazzaniga, Giovanni |
|---|---|
| author |
Fazio, Grazia Palmi, Chiara Attianese, Greta Giordano Biondi, Andrea Rolink, Antonius Cazzaniga, Giovanni |
| spellingShingle |
Fazio, Grazia Palmi, Chiara Attianese, Greta Giordano Biondi, Andrea Rolink, Antonius Cazzaniga, Giovanni Blood PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. Cell Biology Hematology Immunology Biochemistry |
| author_sort |
fazio, grazia |
| spelling |
Fazio, Grazia Palmi, Chiara Attianese, Greta Giordano Biondi, Andrea Rolink, Antonius Cazzaniga, Giovanni 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood.v108.11.1416.1416 <jats:title>Abstract</jats:title> <jats:p>The PAX5/TEL chimeric gene was cloned from the translocation t(9;12)(q11;p13) in an ALL patient. Recent data indicate that the PAX5/TEL fusion defines the cytogenetic entity dic(9;12)(p13;p13), which accounts for about 1% of childhood ALL, almost exclusively B-progenitor ALL.</jats:p> <jats:p>PAX5/TEL is likely to be an aberrant transcription factor, resulting from joining the 5′ region of PAX5 (a transcription factor essential for B cell development) to the 3′ region of TEL/ETV6, containing the Ets-family DNA binding domain.</jats:p> <jats:p>We have cloned the FLAG-full length chimeric PAX5/TEL cDNA in the retroviral vector pMSCV-IRES-GFP (MigR1) to transduce target cells. We have demonstrated a specific nuclear localization of the chimeric protein in NIH3T3 by immunofluorescence analysis. Moreover, we observed a PAX5/TEL dependent decrease of the cellular growth rate in IL-3 dependent murine proB Ba/F3 cells. We further investigated the function of the PAX5/TEL chimeric protein as a potential oncoprotein in murine preBI cells, as a more physiological model.</jats:p> <jats:p>Murine PAX5 −/− preBI cells and wild type preBI cells were purified as B220+/c-KIT+ cells from mouse fetal liver and they were cultured on OP9 and DL1-OP9 stroma cells in presence of IL-7. The OP9 stroma supports B cell proliferation and survival; the DL1-OP9 stroma expresses Delta-like1, one of the Notch ligands, and it’s important to support T cell development. Both PAX5 −/− preBI cells and wild type preBI cells were transduced with the retroviral construct pMSCV-PAX5/TEL-IRES-GFP to analyze cell proliferation, differentiation and growth-dependence on IL-7. Wild type preBI cells expressing PAX5/TEL showed down modulation of CD19 when cultured on OP9 stroma in presence of IL-7; an inverse correlation was observed between the levels of expression of GFP and of CD19. The down modulation of CD19 can be involved in driving the preBI cell into differentiation block. A possible explanation of CD19 repression can rely on a potential competition between PAX5/TEL and endogenous PAX5 to bind PAX5 consensus region on DNA.</jats:p> <jats:p>On OP9 stroma, PAX5/TEL preBI cells are resistant to TGFbeta anti-proliferative and apoptotic effects, with a three-fold increased growth rate than control cells. Although the specific mechanism of PAX5/TEL disruption of TGFbeta signalling pathway remains to be investigated, we propose the TGFbeta resistance by PAX5/TEL as a way to evade the immunosurveillance. PAX5/TEL-preBI cells cultured on DL1-OP9 showed a different phenotype, with up-regulation of c-KIT and down-regulation of CD44.</jats:p> <jats:p>PAX5−/− preBI cells infected with PAX5TEL and grown on OP9 were CD19 negative even in the presence of PAX5TEL. On DL1-OP9 stroma, PAX5TEL cells were able to differentiate maintaining the developmental plasticity of PAX5 −/− preBI cells. These preliminary results indicate a role of PAX5/TEL as a transcription factor, potentially with a suppressor function, down regulating CD19 expression, thus suggesting a function on B cell differentiation. The chimera is able to interfere with TGFbeta pathway, inducing resistance and conferring an advantage in cell survival, evading the immunosurveillance.</jats:p> <jats:p>PAX5TEL do not replace PAX5 functions in PAX5−/− cells, it cannot activate PAX5 target genes as CD19, important for restoring B cell differentiation.</jats:p> <jats:p>Further analyeis are needed to better evaluate the role of PAX5/TEL protein, both in vivo and in vitro models.</jats:p> PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. Blood |
| doi_str_mv |
10.1182/blood.v108.11.1416.1416 |
| facet_avail |
Online Free |
| finc_class_facet |
Biologie Medizin Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC52MTA4LjExLjE0MTYuMTQxNg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC52MTA4LjExLjE0MTYuMTQxNg |
| institution |
DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 |
| imprint |
American Society of Hematology, 2006 |
| imprint_str_mv |
American Society of Hematology, 2006 |
| issn |
0006-4971 1528-0020 |
| issn_str_mv |
0006-4971 1528-0020 |
| language |
English |
| mega_collection |
American Society of Hematology (CrossRef) |
| match_str |
fazio2006pax5telcausesdownregulationofcd19andtgfbetaresistanceinprebicells |
| publishDateSort |
2006 |
| publisher |
American Society of Hematology |
| recordtype |
ai |
| record_format |
ai |
| series |
Blood |
| source_id |
49 |
| title |
PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_unstemmed |
PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_full |
PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_fullStr |
PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_full_unstemmed |
PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_short |
PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_sort |
pax5/tel causes down regulation of cd19 and tgfbeta resistance in prebi cells. |
| topic |
Cell Biology Hematology Immunology Biochemistry |
| url |
http://dx.doi.org/10.1182/blood.v108.11.1416.1416 |
| publishDate |
2006 |
| physical |
1416-1416 |
| description |
<jats:title>Abstract</jats:title>
<jats:p>The PAX5/TEL chimeric gene was cloned from the translocation t(9;12)(q11;p13) in an ALL patient. Recent data indicate that the PAX5/TEL fusion defines the cytogenetic entity dic(9;12)(p13;p13), which accounts for about 1% of childhood ALL, almost exclusively B-progenitor ALL.</jats:p>
<jats:p>PAX5/TEL is likely to be an aberrant transcription factor, resulting from joining the 5′ region of PAX5 (a transcription factor essential for B cell development) to the 3′ region of TEL/ETV6, containing the Ets-family DNA binding domain.</jats:p>
<jats:p>We have cloned the FLAG-full length chimeric PAX5/TEL cDNA in the retroviral vector pMSCV-IRES-GFP (MigR1) to transduce target cells. We have demonstrated a specific nuclear localization of the chimeric protein in NIH3T3 by immunofluorescence analysis. Moreover, we observed a PAX5/TEL dependent decrease of the cellular growth rate in IL-3 dependent murine proB Ba/F3 cells. We further investigated the function of the PAX5/TEL chimeric protein as a potential oncoprotein in murine preBI cells, as a more physiological model.</jats:p>
<jats:p>Murine PAX5 −/− preBI cells and wild type preBI cells were purified as B220+/c-KIT+ cells from mouse fetal liver and they were cultured on OP9 and DL1-OP9 stroma cells in presence of IL-7. The OP9 stroma supports B cell proliferation and survival; the DL1-OP9 stroma expresses Delta-like1, one of the Notch ligands, and it’s important to support T cell development. Both PAX5 −/− preBI cells and wild type preBI cells were transduced with the retroviral construct pMSCV-PAX5/TEL-IRES-GFP to analyze cell proliferation, differentiation and growth-dependence on IL-7. Wild type preBI cells expressing PAX5/TEL showed down modulation of CD19 when cultured on OP9 stroma in presence of IL-7; an inverse correlation was observed between the levels of expression of GFP and of CD19. The down modulation of CD19 can be involved in driving the preBI cell into differentiation block. A possible explanation of CD19 repression can rely on a potential competition between PAX5/TEL and endogenous PAX5 to bind PAX5 consensus region on DNA.</jats:p>
<jats:p>On OP9 stroma, PAX5/TEL preBI cells are resistant to TGFbeta anti-proliferative and apoptotic effects, with a three-fold increased growth rate than control cells. Although the specific mechanism of PAX5/TEL disruption of TGFbeta signalling pathway remains to be investigated, we propose the TGFbeta resistance by PAX5/TEL as a way to evade the immunosurveillance. PAX5/TEL-preBI cells cultured on DL1-OP9 showed a different phenotype, with up-regulation of c-KIT and down-regulation of CD44.</jats:p>
<jats:p>PAX5−/− preBI cells infected with PAX5TEL and grown on OP9 were CD19 negative even in the presence of PAX5TEL. On DL1-OP9 stroma, PAX5TEL cells were able to differentiate maintaining the developmental plasticity of PAX5 −/− preBI cells. These preliminary results indicate a role of PAX5/TEL as a transcription factor, potentially with a suppressor function, down regulating CD19 expression, thus suggesting a function on B cell differentiation. The chimera is able to interfere with TGFbeta pathway, inducing resistance and conferring an advantage in cell survival, evading the immunosurveillance.</jats:p>
<jats:p>PAX5TEL do not replace PAX5 functions in PAX5−/− cells, it cannot activate PAX5 target genes as CD19, important for restoring B cell differentiation.</jats:p>
<jats:p>Further analyeis are needed to better evaluate the role of PAX5/TEL protein, both in vivo and in vitro models.</jats:p> |
| container_issue |
11 |
| container_start_page |
1416 |
| container_title |
Blood |
| container_volume |
108 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792325309035446272 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T12:03:32.853Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=PAX5%2FTEL+Causes+down+Regulation+of+CD19+and+TGFbeta+Resistance+in+PreBI+Cells.&rft.date=2006-11-16&genre=article&issn=1528-0020&volume=108&issue=11&spage=1416&epage=1416&pages=1416-1416&jtitle=Blood&atitle=PAX5%2FTEL+Causes+down+Regulation+of+CD19+and+TGFbeta+Resistance+in+PreBI+Cells.&aulast=Cazzaniga&aufirst=Giovanni&rft_id=info%3Adoi%2F10.1182%2Fblood.v108.11.1416.1416&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792325309035446272 |
| author | Fazio, Grazia, Palmi, Chiara, Attianese, Greta Giordano, Biondi, Andrea, Rolink, Antonius, Cazzaniga, Giovanni |
| author_facet | Fazio, Grazia, Palmi, Chiara, Attianese, Greta Giordano, Biondi, Andrea, Rolink, Antonius, Cazzaniga, Giovanni, Fazio, Grazia, Palmi, Chiara, Attianese, Greta Giordano, Biondi, Andrea, Rolink, Antonius, Cazzaniga, Giovanni |
| author_sort | fazio, grazia |
| container_issue | 11 |
| container_start_page | 1416 |
| container_title | Blood |
| container_volume | 108 |
| description | <jats:title>Abstract</jats:title> <jats:p>The PAX5/TEL chimeric gene was cloned from the translocation t(9;12)(q11;p13) in an ALL patient. Recent data indicate that the PAX5/TEL fusion defines the cytogenetic entity dic(9;12)(p13;p13), which accounts for about 1% of childhood ALL, almost exclusively B-progenitor ALL.</jats:p> <jats:p>PAX5/TEL is likely to be an aberrant transcription factor, resulting from joining the 5′ region of PAX5 (a transcription factor essential for B cell development) to the 3′ region of TEL/ETV6, containing the Ets-family DNA binding domain.</jats:p> <jats:p>We have cloned the FLAG-full length chimeric PAX5/TEL cDNA in the retroviral vector pMSCV-IRES-GFP (MigR1) to transduce target cells. We have demonstrated a specific nuclear localization of the chimeric protein in NIH3T3 by immunofluorescence analysis. Moreover, we observed a PAX5/TEL dependent decrease of the cellular growth rate in IL-3 dependent murine proB Ba/F3 cells. We further investigated the function of the PAX5/TEL chimeric protein as a potential oncoprotein in murine preBI cells, as a more physiological model.</jats:p> <jats:p>Murine PAX5 −/− preBI cells and wild type preBI cells were purified as B220+/c-KIT+ cells from mouse fetal liver and they were cultured on OP9 and DL1-OP9 stroma cells in presence of IL-7. The OP9 stroma supports B cell proliferation and survival; the DL1-OP9 stroma expresses Delta-like1, one of the Notch ligands, and it’s important to support T cell development. Both PAX5 −/− preBI cells and wild type preBI cells were transduced with the retroviral construct pMSCV-PAX5/TEL-IRES-GFP to analyze cell proliferation, differentiation and growth-dependence on IL-7. Wild type preBI cells expressing PAX5/TEL showed down modulation of CD19 when cultured on OP9 stroma in presence of IL-7; an inverse correlation was observed between the levels of expression of GFP and of CD19. The down modulation of CD19 can be involved in driving the preBI cell into differentiation block. A possible explanation of CD19 repression can rely on a potential competition between PAX5/TEL and endogenous PAX5 to bind PAX5 consensus region on DNA.</jats:p> <jats:p>On OP9 stroma, PAX5/TEL preBI cells are resistant to TGFbeta anti-proliferative and apoptotic effects, with a three-fold increased growth rate than control cells. Although the specific mechanism of PAX5/TEL disruption of TGFbeta signalling pathway remains to be investigated, we propose the TGFbeta resistance by PAX5/TEL as a way to evade the immunosurveillance. PAX5/TEL-preBI cells cultured on DL1-OP9 showed a different phenotype, with up-regulation of c-KIT and down-regulation of CD44.</jats:p> <jats:p>PAX5−/− preBI cells infected with PAX5TEL and grown on OP9 were CD19 negative even in the presence of PAX5TEL. On DL1-OP9 stroma, PAX5TEL cells were able to differentiate maintaining the developmental plasticity of PAX5 −/− preBI cells. These preliminary results indicate a role of PAX5/TEL as a transcription factor, potentially with a suppressor function, down regulating CD19 expression, thus suggesting a function on B cell differentiation. The chimera is able to interfere with TGFbeta pathway, inducing resistance and conferring an advantage in cell survival, evading the immunosurveillance.</jats:p> <jats:p>PAX5TEL do not replace PAX5 functions in PAX5−/− cells, it cannot activate PAX5 target genes as CD19, important for restoring B cell differentiation.</jats:p> <jats:p>Further analyeis are needed to better evaluate the role of PAX5/TEL protein, both in vivo and in vitro models.</jats:p> |
| doi_str_mv | 10.1182/blood.v108.11.1416.1416 |
| facet_avail | Online, Free |
| finc_class_facet | Biologie, Medizin, Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC52MTA4LjExLjE0MTYuMTQxNg |
| imprint | American Society of Hematology, 2006 |
| imprint_str_mv | American Society of Hematology, 2006 |
| institution | DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1 |
| issn | 0006-4971, 1528-0020 |
| issn_str_mv | 0006-4971, 1528-0020 |
| language | English |
| last_indexed | 2024-03-01T12:03:32.853Z |
| match_str | fazio2006pax5telcausesdownregulationofcd19andtgfbetaresistanceinprebicells |
| mega_collection | American Society of Hematology (CrossRef) |
| physical | 1416-1416 |
| publishDate | 2006 |
| publishDateSort | 2006 |
| publisher | American Society of Hematology |
| record_format | ai |
| recordtype | ai |
| series | Blood |
| source_id | 49 |
| spelling | Fazio, Grazia Palmi, Chiara Attianese, Greta Giordano Biondi, Andrea Rolink, Antonius Cazzaniga, Giovanni 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood.v108.11.1416.1416 <jats:title>Abstract</jats:title> <jats:p>The PAX5/TEL chimeric gene was cloned from the translocation t(9;12)(q11;p13) in an ALL patient. Recent data indicate that the PAX5/TEL fusion defines the cytogenetic entity dic(9;12)(p13;p13), which accounts for about 1% of childhood ALL, almost exclusively B-progenitor ALL.</jats:p> <jats:p>PAX5/TEL is likely to be an aberrant transcription factor, resulting from joining the 5′ region of PAX5 (a transcription factor essential for B cell development) to the 3′ region of TEL/ETV6, containing the Ets-family DNA binding domain.</jats:p> <jats:p>We have cloned the FLAG-full length chimeric PAX5/TEL cDNA in the retroviral vector pMSCV-IRES-GFP (MigR1) to transduce target cells. We have demonstrated a specific nuclear localization of the chimeric protein in NIH3T3 by immunofluorescence analysis. Moreover, we observed a PAX5/TEL dependent decrease of the cellular growth rate in IL-3 dependent murine proB Ba/F3 cells. We further investigated the function of the PAX5/TEL chimeric protein as a potential oncoprotein in murine preBI cells, as a more physiological model.</jats:p> <jats:p>Murine PAX5 −/− preBI cells and wild type preBI cells were purified as B220+/c-KIT+ cells from mouse fetal liver and they were cultured on OP9 and DL1-OP9 stroma cells in presence of IL-7. The OP9 stroma supports B cell proliferation and survival; the DL1-OP9 stroma expresses Delta-like1, one of the Notch ligands, and it’s important to support T cell development. Both PAX5 −/− preBI cells and wild type preBI cells were transduced with the retroviral construct pMSCV-PAX5/TEL-IRES-GFP to analyze cell proliferation, differentiation and growth-dependence on IL-7. Wild type preBI cells expressing PAX5/TEL showed down modulation of CD19 when cultured on OP9 stroma in presence of IL-7; an inverse correlation was observed between the levels of expression of GFP and of CD19. The down modulation of CD19 can be involved in driving the preBI cell into differentiation block. A possible explanation of CD19 repression can rely on a potential competition between PAX5/TEL and endogenous PAX5 to bind PAX5 consensus region on DNA.</jats:p> <jats:p>On OP9 stroma, PAX5/TEL preBI cells are resistant to TGFbeta anti-proliferative and apoptotic effects, with a three-fold increased growth rate than control cells. Although the specific mechanism of PAX5/TEL disruption of TGFbeta signalling pathway remains to be investigated, we propose the TGFbeta resistance by PAX5/TEL as a way to evade the immunosurveillance. PAX5/TEL-preBI cells cultured on DL1-OP9 showed a different phenotype, with up-regulation of c-KIT and down-regulation of CD44.</jats:p> <jats:p>PAX5−/− preBI cells infected with PAX5TEL and grown on OP9 were CD19 negative even in the presence of PAX5TEL. On DL1-OP9 stroma, PAX5TEL cells were able to differentiate maintaining the developmental plasticity of PAX5 −/− preBI cells. These preliminary results indicate a role of PAX5/TEL as a transcription factor, potentially with a suppressor function, down regulating CD19 expression, thus suggesting a function on B cell differentiation. The chimera is able to interfere with TGFbeta pathway, inducing resistance and conferring an advantage in cell survival, evading the immunosurveillance.</jats:p> <jats:p>PAX5TEL do not replace PAX5 functions in PAX5−/− cells, it cannot activate PAX5 target genes as CD19, important for restoring B cell differentiation.</jats:p> <jats:p>Further analyeis are needed to better evaluate the role of PAX5/TEL protein, both in vivo and in vitro models.</jats:p> PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. Blood |
| spellingShingle | Fazio, Grazia, Palmi, Chiara, Attianese, Greta Giordano, Biondi, Andrea, Rolink, Antonius, Cazzaniga, Giovanni, Blood, PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells., Cell Biology, Hematology, Immunology, Biochemistry |
| title | PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_full | PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_fullStr | PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_full_unstemmed | PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_short | PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| title_sort | pax5/tel causes down regulation of cd19 and tgfbeta resistance in prebi cells. |
| title_unstemmed | PAX5/TEL Causes down Regulation of CD19 and TGFbeta Resistance in PreBI Cells. |
| topic | Cell Biology, Hematology, Immunology, Biochemistry |
| url | http://dx.doi.org/10.1182/blood.v108.11.1416.1416 |